Agilon Health, Inc. Hits New 52-Week High of $116.46

Agilon Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 116.46 on June 11, 2026. This achievement marks a remarkable performance for the small-cap company, which operates within the Pharmaceuticals & Biotechnology industry. Over the past year, Agilon Health has demonstrated an impressive growth trajectory, with a staggering 1,633.73% increase in its stock price, significantly outpacing the S&P 500's performance of 22.78%. Despite its recent success, Agilon Health remains a loss-making entity, as indicated by its negative price-to-earnings ratio. The company's market capitalization stands at USD 164 million, reflecting its small-cap status. Additionally, Agilon Health has a price-to-book ratio of 1.30, while its debt-to-equity ratio is reported at -1.97, indicating a unique financial structure. The company does not currently offer a dividend yield, which is consistent with its focus on growth and reinvestment in its operations. This recent high underscores Agilon Health's notable position in the market and its extraordinary performance over the past year.